Serum Institute Partners with Gates MRI to Make Experimental TB Vaccine

SII To Manufacture TB Vaccine

Serum Institute of India (SII) has entered into an agreement with the Gates Medical Research Institute (Gates MRI) to develop manufacturing capabilities for the investigational

Serum Institute Signs Gates MRI Pact, Commits Over USD 100 Million for TB Vaccine Production

Hyderabad: Serum Institute of India said on Thursday it would manufacture an experimental tuberculosis vaccine under an agreement with the Gates Medical Research Institute, in what is likely to be the...

Serum Institute To Make Experimental Tuberculosis Vaccine: Could It Change TB Prevention?

India's Serum Institute of India (SII) has announced that it will manufacture an experimental tuberculosis (TB) vaccine under an agreement with the Gates Medic

Gates MRI, Serum Institute sign deal to manufacture novel TB vaccine candidate

Currently in a Phase 3 clinical trial, M72/AS01E has the potential to become the first new TB vaccine introduced in more than a century.

Serum Institute to invest $ 100 million for TB vaccine, signs agreement with Gates MRI

The Gates Medical Research Institute and Serum Institute of India have signed an agreement to mass-produce the M72/AS01E tuberculosis vaccine candidate, potentially introducing the first new TB vaccine in over a century.

SII & Gates MRI ink pact to manufacture new TB vaccine candidate after successful Phase 3 trials

Serum Institute of India and Gates MRI to manufacture M72/AS01E TB vaccine candidate in Phase 3, aiming for scalable supply for high-burden countries.